To evaluate whether the T cells in glioma-bearing brains express FcγRIIb, which can bind and be regulated by FGL2 in the tumor microenvironment, FcγRIIB expression was detected on T cells in DBT tumor-bearing brains. The gene discussed is FGL2; the disease is central nervous system cancer.